US Stock MarketDetailed Quotes

Takeda Pharmaceutical (TAK)

Watchlist

16.385
-0.245-1.47%

Trading Apr 27 15:08 ET

51.76BMarket Cap73.81P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical (TAK) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2025

(Q2)Sep 30, 2025

(Q1)Jun 30, 2025

(FY)Mar 31, 2025

(Q4)Mar 31, 2025

(Q3)Dec 31, 2024

(Q2)Sep 30, 2024

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

Total revenue

4.16%1.19T

-5.38%1.11T

-8.39%1.11T

7.45%4.58T

0.24%1.05T

2.96%1.14T

12.75%1.18T

14.11%1.21T

5.87%4.26T

9.91%1.05T

Operating revenue

4.16%1.19T

-5.38%1.11T

-8.39%1.11T

7.45%4.58T

0.24%1.05T

2.96%1.14T

12.75%1.18T

14.11%1.21T

5.87%4.26T

9.91%1.05T

Cost of revenue

-3.77%401.15B

-3.61%380.06B

-0.59%384.68B

10.76%1.58T

-0.11%382.08B

9.85%416.87B

14.76%394.31B

20.50%386.95B

14.68%1.43T

23.48%382.5B

Gross profit

8.70%790.55B

-6.27%732.74B

-12.06%722.01B

5.79%3T

0.44%671.32B

-0.61%727.25B

11.75%781.73B

11.33%821.04B

1.93%2.84T

3.40%668.37B

Operating expense

-5.84%621.73B

11.09%663.74B

-17.91%537.45B

1.80%2.52T

14.52%602.78B

-16.71%660.31B

-20.21%597.48B

15.08%654.71B

12.54%2.47T

14.30%526.35B

Selling and administrative expenses

4.51%282.78B

-5.49%253.55B

-5.24%255.89B

4.83%1.1T

3.73%295.87B

1.15%270.59B

6.06%268.28B

8.83%270.03B

5.67%1.05T

11.95%285.23B

Research and development costs

2.96%175.23B

-8.02%161.48B

-14.59%143.89B

0.04%730.23B

10.29%216.01B

-9.17%170.19B

-4.56%175.56B

3.52%168.46B

15.25%729.92B

21.69%195.86B

Depreciation amortization depletion

5.19%141.91B

44.06%205.16B

-19.16%131.64B

-1.36%643.23B

39.94%203.08B

-46.69%134.91B

-40.72%142.41B

25.81%162.83B

20.22%652.12B

8.92%145.11B

-Depreciation and amortization

5.19%141.91B

44.06%205.16B

-19.16%131.64B

-1.36%643.23B

39.94%203.08B

-46.69%134.91B

-40.72%142.41B

25.81%162.83B

20.22%652.12B

8.92%145.11B

Other operating expenses

-74.24%21.8B

288.16%43.55B

-88.70%6.03B

5.67%37.05B

-12.33%-112.17B

-0.22%84.61B

-84.35%11.22B

86.29%53.38B

55.70%35.06B

-12.90%-99.86B

Operating profit

152.19%168.82B

-62.55%69B

10.96%184.57B

32.74%486.06B

-51.74%68.54B

209.60%66.94B

473.41%184.25B

-1.33%166.33B

-37.71%366.17B

-23.59%142.02B

Net non-operating interest income expense

7.33%-35.76B

39.78%-38.74B

-15.12%-33.4B

-0.86%-141.67B

29.98%-9.73B

13.83%-38.58B

-32.21%-64.34B

12.40%-29.01B

-13.84%-140.46B

73.14%-13.9B

Non-operating interest income

1,357.46%87.87B

978.62%44.4B

140.43%73.76B

73.90%19.64B

76.54%-8.17B

-132.07%-6.99B

-56.02%4.12B

15.96%30.68B

105.03%11.29B

29.85%-34.81B

Non-operating interest expense

291.27%123.63B

21.45%83.14B

79.52%107.16B

14.87%137.31B

57.78%-22.43B

-52.54%31.6B

17.98%68.45B

0.19%59.69B

2.19%119.54B

-442.57%-53.13B

Total other finance cost

----

-25.53%24B

----

170.31%32.22B

----

Other net income (expense)

140.93%799M

-288.60%-2.08B

24.72%-536M

2.08%-169.31B

5.43%-166.11B

-101.17%-1.95B

-126.42%-535M

-70.33%-712M

-93.55%-172.91B

-103.75%-175.64B

Gain on sale of security

----

183.25%7.6B

----

-241.82%-9.13B

----

Earnings from equity interest

140.93%799M

-288.60%-2.08B

24.72%-536M

-161.58%-3.99B

-121.03%-787M

-273.67%-1.95B

-126.42%-535M

-70.33%-712M

-53.05%6.47B

-77.88%3.74B

Special income (charges)

----

-1.57%-172.92B

----

-55.39%-170.25B

----

-Less：Restructuring and merger&acquisition

----

24.89%127.53B

----

61.51%102.12B

----

-Less:Other special charges

----

-40.72%37.57B

----

157.52%63.37B

----

-Write off

----

44.34%18.38B

----

-58.42%12.74B

----

-Gain on sale of business

----

30.23%10.2B

----

15.04%7.83B

----

-Gain on sale of property,plant,equipment

----

152.08%363M

----

-93.12%144M

----

Income before tax

406.93%133.86B

-76.40%28.17B

10.27%150.63B

231.66%175.08B

-125.79%-107.3B

-56.89%26.41B

224.37%119.37B

1.16%136.6B

-85.93%52.79B

-199.18%-47.52B

Income tax

1,071.50%30.13B

46.35%39.9B

-36.20%26.35B

173.23%66.94B

90.57%-4.2B

105.78%2.57B

156.79%27.27B

-9.47%41.3B

-257.46%-91.41B

-365.38%-44.53B

Net income

335.21%103.73B

-112.73%-11.73B

30.41%124.28B

-25.00%108.14B

-3,343.49%-103.1B

-77.46%23.84B

292.01%92.11B

6.59%95.3B

-54.52%144.2B

-109.62%-2.99B

Net income continuous Operations

335.21%103.73B

-112.73%-11.73B

30.41%124.28B

-25.00%108.14B

-3,343.49%-103.1B

-77.46%23.84B

292.00%92.11B

6.59%95.3B

-54.52%144.2B

-109.62%-2.99B

Minority interest income

104.35%94M

18.03%72M

-29.41%36M

65.38%215M

137.50%57M

31.43%46M

3.39%61M

363.64%51M

519.05%130M

1,100.00%24M

Net income attributable to the parent company

335.66%103.64B

-112.82%-11.8B

30.44%124.24B

-25.08%107.93B

-3,317.99%-103.16B

-77.50%23.79B

291.64%92.05B

6.55%95.25B

-54.56%144.07B

-109.69%-3.02B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

335.66%103.64B

-112.82%-11.8B

30.44%124.24B

-25.08%107.93B

-3,317.99%-103.16B

-77.50%23.79B

291.64%92.05B

6.55%95.25B

-54.56%144.07B

-109.69%-3.02B

Basic earnings per share

342.40%32.87

-113.47%-3.915

30.79%39.7

-25.77%34.18

-3,151.24%-32.675

-78.01%7.43

289.50%29.07

5.56%30.355

-54.92%46.045

-110.07%-1.005

Diluted earnings per share

343.62%32.34

-113.70%-3.915

30.51%39.115

-26.25%33.615

-3,151.24%-32.675

-78.20%7.29

286.34%28.585

4.94%29.97

-54.86%45.58

-110.42%-1.005

Dividend per share

2.80%47.8738

5.89%97.2997

14.71%50.7303

-2.29%46.5694

3.35%91.889

7.08%44.2266

Currency Unit

JPY

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Dec 31, 2025	(Q2)Sep 30, 2025	(Q1)Jun 30, 2025	(FY)Mar 31, 2025	(Q4)Mar 31, 2025	(Q3)Dec 31, 2024	(Q2)Sep 30, 2024	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024
Total revenue	4.16%1.19T	-5.38%1.11T	-8.39%1.11T	7.45%4.58T	0.24%1.05T	2.96%1.14T	12.75%1.18T	14.11%1.21T	5.87%4.26T	9.91%1.05T
Operating revenue	4.16%1.19T	-5.38%1.11T	-8.39%1.11T	7.45%4.58T	0.24%1.05T	2.96%1.14T	12.75%1.18T	14.11%1.21T	5.87%4.26T	9.91%1.05T
Cost of revenue	-3.77%401.15B	-3.61%380.06B	-0.59%384.68B	10.76%1.58T	-0.11%382.08B	9.85%416.87B	14.76%394.31B	20.50%386.95B	14.68%1.43T	23.48%382.5B
Gross profit	8.70%790.55B	-6.27%732.74B	-12.06%722.01B	5.79%3T	0.44%671.32B	-0.61%727.25B	11.75%781.73B	11.33%821.04B	1.93%2.84T	3.40%668.37B
Operating expense	-5.84%621.73B	11.09%663.74B	-17.91%537.45B	1.80%2.52T	14.52%602.78B	-16.71%660.31B	-20.21%597.48B	15.08%654.71B	12.54%2.47T	14.30%526.35B
Selling and administrative expenses	4.51%282.78B	-5.49%253.55B	-5.24%255.89B	4.83%1.1T	3.73%295.87B	1.15%270.59B	6.06%268.28B	8.83%270.03B	5.67%1.05T	11.95%285.23B
Research and development costs	2.96%175.23B	-8.02%161.48B	-14.59%143.89B	0.04%730.23B	10.29%216.01B	-9.17%170.19B	-4.56%175.56B	3.52%168.46B	15.25%729.92B	21.69%195.86B
Depreciation amortization depletion	5.19%141.91B	44.06%205.16B	-19.16%131.64B	-1.36%643.23B	39.94%203.08B	-46.69%134.91B	-40.72%142.41B	25.81%162.83B	20.22%652.12B	8.92%145.11B
-Depreciation and amortization	5.19%141.91B	44.06%205.16B	-19.16%131.64B	-1.36%643.23B	39.94%203.08B	-46.69%134.91B	-40.72%142.41B	25.81%162.83B	20.22%652.12B	8.92%145.11B
Other operating expenses	-74.24%21.8B	288.16%43.55B	-88.70%6.03B	5.67%37.05B	-12.33%-112.17B	-0.22%84.61B	-84.35%11.22B	86.29%53.38B	55.70%35.06B	-12.90%-99.86B
Operating profit	152.19%168.82B	-62.55%69B	10.96%184.57B	32.74%486.06B	-51.74%68.54B	209.60%66.94B	473.41%184.25B	-1.33%166.33B	-37.71%366.17B	-23.59%142.02B
Net non-operating interest income expense	7.33%-35.76B	39.78%-38.74B	-15.12%-33.4B	-0.86%-141.67B	29.98%-9.73B	13.83%-38.58B	-32.21%-64.34B	12.40%-29.01B	-13.84%-140.46B	73.14%-13.9B
Non-operating interest income	1,357.46%87.87B	978.62%44.4B	140.43%73.76B	73.90%19.64B	76.54%-8.17B	-132.07%-6.99B	-56.02%4.12B	15.96%30.68B	105.03%11.29B	29.85%-34.81B
Non-operating interest expense	291.27%123.63B	21.45%83.14B	79.52%107.16B	14.87%137.31B	57.78%-22.43B	-52.54%31.6B	17.98%68.45B	0.19%59.69B	2.19%119.54B	-442.57%-53.13B
Total other finance cost	----	----	----	-25.53%24B	----	----	----	----	170.31%32.22B	----
Other net income (expense)	140.93%799M	-288.60%-2.08B	24.72%-536M	2.08%-169.31B	5.43%-166.11B	-101.17%-1.95B	-126.42%-535M	-70.33%-712M	-93.55%-172.91B	-103.75%-175.64B
Gain on sale of security	----	----	----	183.25%7.6B	----	----	----	----	-241.82%-9.13B	----
Earnings from equity interest	140.93%799M	-288.60%-2.08B	24.72%-536M	-161.58%-3.99B	-121.03%-787M	-273.67%-1.95B	-126.42%-535M	-70.33%-712M	-53.05%6.47B	-77.88%3.74B
Special income (charges)	----	----	----	-1.57%-172.92B	----	----	----	----	-55.39%-170.25B	----
-Less：Restructuring and merger&acquisition	----	----	----	24.89%127.53B	----	----	----	----	61.51%102.12B	----
-Less:Other special charges	----	----	----	-40.72%37.57B	----	----	----	----	157.52%63.37B	----
-Write off	----	----	----	44.34%18.38B	----	----	----	----	-58.42%12.74B	----
-Gain on sale of business	----	----	----	30.23%10.2B	----	----	----	----	15.04%7.83B	----
-Gain on sale of property,plant,equipment	----	----	----	152.08%363M	----	----	----	----	-93.12%144M	----
Income before tax	406.93%133.86B	-76.40%28.17B	10.27%150.63B	231.66%175.08B	-125.79%-107.3B	-56.89%26.41B	224.37%119.37B	1.16%136.6B	-85.93%52.79B	-199.18%-47.52B
Income tax	1,071.50%30.13B	46.35%39.9B	-36.20%26.35B	173.23%66.94B	90.57%-4.2B	105.78%2.57B	156.79%27.27B	-9.47%41.3B	-257.46%-91.41B	-365.38%-44.53B
Net income	335.21%103.73B	-112.73%-11.73B	30.41%124.28B	-25.00%108.14B	-3,343.49%-103.1B	-77.46%23.84B	292.01%92.11B	6.59%95.3B	-54.52%144.2B	-109.62%-2.99B
Net income continuous Operations	335.21%103.73B	-112.73%-11.73B	30.41%124.28B	-25.00%108.14B	-3,343.49%-103.1B	-77.46%23.84B	292.00%92.11B	6.59%95.3B	-54.52%144.2B	-109.62%-2.99B
Minority interest income	104.35%94M	18.03%72M	-29.41%36M	65.38%215M	137.50%57M	31.43%46M	3.39%61M	363.64%51M	519.05%130M	1,100.00%24M
Net income attributable to the parent company	335.66%103.64B	-112.82%-11.8B	30.44%124.24B	-25.08%107.93B	-3,317.99%-103.16B	-77.50%23.79B	291.64%92.05B	6.55%95.25B	-54.56%144.07B	-109.69%-3.02B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	335.66%103.64B	-112.82%-11.8B	30.44%124.24B	-25.08%107.93B	-3,317.99%-103.16B	-77.50%23.79B	291.64%92.05B	6.55%95.25B	-54.56%144.07B	-109.69%-3.02B
Basic earnings per share	342.40%32.87	-113.47%-3.915	30.79%39.7	-25.77%34.18	-3,151.24%-32.675	-78.01%7.43	289.50%29.07	5.56%30.355	-54.92%46.045	-110.07%-1.005
Diluted earnings per share	343.62%32.34	-113.70%-3.915	30.51%39.115	-26.25%33.615	-3,151.24%-32.675	-78.20%7.29	286.34%28.585	4.94%29.97	-54.86%45.58	-110.42%-1.005
Dividend per share	0	2.80%47.8738	0	5.89%97.2997	14.71%50.7303	0	-2.29%46.5694	0	3.35%91.889	7.08%44.2266
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm